Two germicides containing 0.5 and 1% titratable @entity1496 were tested for efficacy against the development of new intramammary infections (IMI) caused by @entity794 and @entity5967 . The two trials for postmilking teat dip used a model for experimental challenge that was recommended by the National @entity1271 Council. The 0.5% @entity1496 formulation reduced new Staph. aureus IMI by 78.2% and reduced new Strep. agalactiae IMI by 73.2%. The 1% @entity1496 product reduced new Staph. aureus IMI by 43.5% and reduced new Strep. agalactiae IMI by 46.4%. No adverse effects on the condition of teat skin or on teat ends were observed over the course of the trials. At the completion of each trial, the teat skin of dipped quarters was characterized as normal, smooth skin that was free from scales, cracks, or chapping; the teat orifice was characterized as smooth without evidence of @entity146 .

Evaluation of two iodophor teat germicides: activity against @entity794 and XXXX .

@entity1496 :: ('MESH:D007455', 'Chemical') :: ['iodine'] @entity5967 :: ('1311', 'Species') :: ['Streptococcus agalactiae'] @entity146 :: ('MESH:D001523', 'Disease') :: ['irritation'] @entity794 :: ('1280', 'Species') :: ['Staphylococcus aureus'] @entity1271 :: ('MESH:D008413', 'Disease') :: ['Mastitis']
@entity5967 :: (1311,Species) :: ['Streptococcus agalactiae']
